Cargando…
COVID-19 infection, fluctuations in the clozapine/norclozapine levels and metabolic ratio and clozapine toxicity: An illustrative case-report
Autores principales: | Chengappa, K.N. Roy, Thomas, Jane, Kahn, Charles E., Clinebell, Kimberly, Mullen, Kelly K., Arbutiski, Lori, Ivanov, Emil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117158/ https://www.ncbi.nlm.nih.gov/pubmed/35605549 http://dx.doi.org/10.1016/j.schres.2022.05.009 |
Ejemplares similares
-
Steady-State Clozapine and Norclozapine Pharmacokinetics in Maori and European Patients
por: Menkes, David B., et al.
Publicado: (2017) -
Effect of Clonazepam Co-Administered with Clozapine on the Serum Clozapine and Norclozapine Concentration of Patients with Schizophrenia: A Retrospective Survey
Publicado: (2016) -
Change in plasma concentration of clozapine and norclozapine following a switch of oral formulation
por: Keshavarzi, Farinaz, et al.
Publicado: (2020) -
Population Pharmacokinetics of Clozapine and Norclozapine and Switchability Assessment between Brands in Uruguayan Patients with Schizophrenia
por: Olmos, Ismael, et al.
Publicado: (2019) -
Prediction of brain clozapine and norclozapine concentrations in humans from a scaled pharmacokinetic model for rat brain and plasma pharmacokinetics
por: Li, Claire H, et al.
Publicado: (2014)